Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study

Abstract Objective: This study was conducted to evaluate once-weekly liposomal amphotericin B (L-AmB) for Candida prophylaxis in very low birth weight (VLBW) neonates. Methods: This prospective, randomized, open-label, placebo-controlled study included neonates who were

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2010-02, Vol.32 (2), p.265-271
Hauptverfasser: Arrieta, Antonio C., MD, Shea, Kathy, BA, Dhar, Vijay, MD, Cleary, John P., MD, Kukreja, Sudeep, MD, Morris, Mindy, RNP, Vargas-Shiraishi, Ofelia M., MS, Ashouri, Negar, MD, Singh, Jasjit, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objective: This study was conducted to evaluate once-weekly liposomal amphotericin B (L-AmB) for Candida prophylaxis in very low birth weight (VLBW) neonates. Methods: This prospective, randomized, open-label, placebo-controlled study included neonates who were
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2010.02.016